Skip to content
Colorectal Cancer Clinical Trials

Ann Arbor, Michigan

Colorectal cancer clinical trials in Ann Arbor, MI

29 colorectal cancer studies are recruiting participants at sites in Ann Arbor as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.

Call (888) 385-9581
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Ann Arbor at a glance

  • 29 studies are recruiting at a site in Ann Arbor.
  • By phase: Phase 1 (4), Phase 1/2 (4), Phase 2 (3), Phase 2/3 (1), Phase 3 (7), No phase (5), Observational (5). Studies of devices and behavioral approaches have no phase.
  • By sponsor: university, hospital or other (15), industry (13), government (1).
  • Most recent update to one of these records: November 16, 2026.

Studies recruiting in Ann Arbor

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Study site
    University of Michigan Rogel Cancer Center
    Registry record
    NCT05863195 · updated
  2. A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Vividion Therapeutics, Inc.
    Study site
    University of Michigan
    Registry record
    NCT06004245 · updated
  3. A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Verastem, Inc.
    Study site
    University of Michigan
    Registry record
    NCT07020221 · updated
  4. Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    SWOG Cancer Research Network
    Study sites
    Trinity Health IHA - Obstetrics and Gynecology West Arbor · Trinity Health Saint Joseph Mercy Hospital Ann Arbor
    Registry record
    NCT07018869 · updated
  5. Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer

    • Observational
    • Ages 60 and older
    • All sexes
    Sponsor
    Wake Forest University Health Sciences
    Study site
    Trinity Health Saint Joseph Mercy Hospital Ann Arbor
    Registry record
    NCT03998202 · updated
  6. Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    NRG Oncology
    Study sites
    Trinity Health Saint Joseph Mercy Hospital Ann Arbor · University of Michigan Rogel Cancer Center
    Registry record
    NCT05174169 · updated
  7. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    • Observational
    • Ages 40 to 75
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Trinity Health Saint Joseph Mercy Hospital Ann Arbor
    Registry record
    NCT05334069 · updated
  8. Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Wake Forest University Health Sciences
    Study site
    Trinity Health Saint Joseph Mercy Hospital Ann Arbor
    Registry record
    NCT06418204 · updated
  9. Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study sites
    Trinity Health IHA - Obstetrics and Gynecology West Arbor · Trinity Health Saint Joseph Mercy Hospital Ann Arbor
    Registry record
    NCT07283939 · updated
  10. A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Study site
    University of Michigan Health System
    Registry record
    NCT05379595 · updated
  11. Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Trinity Health Saint Joseph Mercy Hospital Ann Arbor
    Registry record
    NCT05673148 · updated
  12. A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Study sites
    University of Michigan · VA Ann Arbor Healthcare System
    Registry record
    NCT06662786 · updated
  13. A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Study site
    University of Michigan Rogel Cancer Center
    Registry record
    NCT06750094 · updated
  14. Family Communications After Genetic Testing

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Trinity Health Saint Joseph Mercy Hospital Ann Arbor
    Registry record
    NCT07143487 · updated
  15. FITting Non-invasive Tests in Lynch Syndrome Surveillance

    • No phase
    • Ages 20 to 80
    • All sexes
    Sponsor
    University of Chicago
    Study site
    University of Michigan
    Registry record
    NCT06898996 · updated
  16. A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Incyte Corporation
    Study site
    Trinity Health St Joseph Mercy Ann Arbor
    Registry record
    NCT07284849 · updated
  17. A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Study site
    University Of Michigan /ID# 270790
    Registry record
    NCT06820463 · updated
  18. The Cancer of the Pancreas Screening-5 CAPS5)Study

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Johns Hopkins University
    Study site
    University of Michigan
    Registry record
    NCT02000089 · updated
  19. Testing for Safety and Colorectal Cancer Preventive Effects of ONC201

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    University of Michigan Rogel Cancer Center
    Registry record
    NCT05630794 · updated
  20. A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Study site
    University of Michigan Health System - Ann Arbor /ID# 273511
    Registry record
    NCT07023289 · updated
  21. Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

    • No phase
    • Ages 65 to 82
    • All sexes
    Sponsor
    Dartmouth-Hitchcock Medical Center
    Study site
    University of Michigan Health
    Registry record
    NCT05612347 · updated
  22. A Phase 1/1b Study of IAM1363 in HER2 Cancers

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Iambic Therapeutics, Inc
    Study site
    University of Michigan
    Registry record
    NCT06253871 · updated
  23. Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

    • Phase 1
    • Ages 12 to 85
    • All sexes
    Sponsor
    Inhibrx Biosciences, Inc
    Study site
    University of Michigan
    Registry record
    NCT03715933 · updated
  24. Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

    • Phase 1/2
    • From 12 months, up to 30 years
    • All sexes
    Sponsor
    Children's Oncology Group
    Study site
    C S Mott Children's Hospital
    Registry record
    NCT04851119 · updated
  25. Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Rapamycin Holdings Inc.
    Study site
    University of Michigan
    Registry record
    NCT06950385 · updated
  26. Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Michigan Rogel Cancer Center
    Study site
    University of Michigan Rogel Cancer Center
    Registry record
    NCT06641310 · updated
  27. Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Michigan Rogel Cancer Center
    Study site
    University of Michigan
    Registry record
    NCT00843375 · updated
  28. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    • Observational
    • All ages
    • All sexes
    Sponsor
    Massive Bio, Inc.
    Study site
    Massive Bio SYNERGY-AI site
    Registry record
    NCT03452774 · updated
  29. A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    LigaChem Biosciences, Inc.
    Study site
    University of Michigan
    Registry record
    NCT05941507 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Ann Arbor, MI on ClinicalTrials.gov.

Ask about studies near Ann Arbor

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Michigan

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 385-9581

or send a short form

How should we reach you?

Call